Orexigen Therapeutics, Inc. (NASDAQ:OREX) Posted Basic Consolidated EPS Of $-5.2381

0

Orexigen Therapeutics, Inc. (NASDAQ:OREX) annual basic consolidated EPS was $-5.2381 for the period ended 2015-12-31. The basic consolidated EPS was $-5.2381 for the quarter ended 2015-12-31.

EPS from continuing operations

Orexigen Therapeutics, Inc. (NASDAQ:OREX)’s basic EPS from continuing operations was $-5.2381 for the fiscal year 2015-12-31. For the quarter ended 2015-12-31 it stood at $-5.2381

EPS contribution from parent

From the parent company Orexigen Therapeutics, Inc. (NASDAQ:OREX) posted basic EPS of $-5.2381 for the fiscal ended 2015-12-31. For the quarter that ended on 2015-12-31 the figure stood at $-5.2381.

Basic net EPS

The Basic net EPS of Orexigen Therapeutics, Inc. (NASDAQ:OREX) was $-5.2 for the period ended 2015-12-31. The figure stood at $-5.2 for the quarter that ended 2015-12-31.

Consolidated diluted EPS

The consolidated diluted EPS for the fiscal year 2015-12-31 stood at $-5.2381. While the figure for the quarter ended 2015-12-31 stood at $-5.2381.

Basic diluted EPS

The diluted EPS from continuing operation of Orexigen Therapeutics, Inc. (NASDAQ:OREX) stood at $-5.2381 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-5.2381

Net diluted EPS

The Net diluted EPS was $-5.2 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-5.2.

Diluted EPS from parent

Orexigen Therapeutics, Inc. (NASDAQ:OREX) diluted EPS from the parent company for the fiscal 2015-12-31 was $-5.2381. The figure for the quarter ended 2015-12-31 was $-5.2381

The net basic EPS was $-5.2 for fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 was $-5.2

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 47 times, 1 visits today)